BioCryst Pharmaceuticals, Inc. announced that the company has appointed Machelle Sanders, to its board of directors. Ms. Sanders currently serves on the boards of directors of Radius Health and Novan.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 USD | +18.66% | +24.71% | +6.18% |
May. 15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
May. 15 | BioCryst Pharmaceuticals Shares Rise 20% Following Disclosure of Executive Share Purchases | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.18% | 1.31B | |
+7.52% | 113B | |
+11.38% | 106B | |
+0.96% | 22.27B | |
-12.64% | 22.22B | |
-5.52% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- BCRX Stock
- News BioCryst Pharmaceuticals, Inc.
- BioCryst Appoints Machelle Sanders to Board of Directors